Adipose Tissue and Adipose-Tissue-Derived Cell Therapies for the Treatment of the Face and Hands of Patients Suffering from Systemic Sclerosis.

Biomedicines · 2023 · PMC9953720 · PMID 36830886

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

showed a trendno p-value reported

The analysis of the primary endpoint (change in CHFS at 24 and 48 weeks after treatment) showed a trend in favour of the AD-SVF group at 24 and 48 weeks without statistical significance.

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.